Matches in DBpedia 2016-04 for { ?s ?p "BioDrugs is a peer-reviewed pharmacology journal.It has an impact factor of 2.989.It is published by Adis International (Springer Science + Business Media)BioDrugs aims to advance discussion and evaluation of the latest developments in the clinical application of biotechnology for the treatment of human disease by providing a programme of review articles and original research covering the most important aspects of biotechnology-based pharmaceuticals, diagnostic products and innovations in bio-tech therapy. This includes novel drug delivery systems; protein/peptide therapeutics; monoclonal antibodies, antibody fragments and antibody engineering; biosimilars; cytokines and cytokine receptors; recombinant DNA and gene regulation technology; gene therapy; nucleic acid therapeutics and diagnostics; stem cell therapies; drug target validation; glycolated and pegylated therapeutics; and pioneering technologies in drug design and development. BioDrugs publishes articles on all areas of medicine. Abstracted/Indexed in:- PubMed/Medline, SCOPUS, EMBASE, Google Scholar, EBSCO, CSA, CAB International, Academic OneFile, Academic Search, ASFA, CAB Abstracts, Current Abstracts, Expanded Academic, Global Health, Health Reference Center Academic, OCLC, SCImago, Summon by Serial Solutions"@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- BioDrugs abstract "BioDrugs is a peer-reviewed pharmacology journal.It has an impact factor of 2.989.It is published by Adis International (Springer Science + Business Media)BioDrugs aims to advance discussion and evaluation of the latest developments in the clinical application of biotechnology for the treatment of human disease by providing a programme of review articles and original research covering the most important aspects of biotechnology-based pharmaceuticals, diagnostic products and innovations in bio-tech therapy. This includes novel drug delivery systems; protein/peptide therapeutics; monoclonal antibodies, antibody fragments and antibody engineering; biosimilars; cytokines and cytokine receptors; recombinant DNA and gene regulation technology; gene therapy; nucleic acid therapeutics and diagnostics; stem cell therapies; drug target validation; glycolated and pegylated therapeutics; and pioneering technologies in drug design and development. BioDrugs publishes articles on all areas of medicine. Abstracted/Indexed in:- PubMed/Medline, SCOPUS, EMBASE, Google Scholar, EBSCO, CSA, CAB International, Academic OneFile, Academic Search, ASFA, CAB Abstracts, Current Abstracts, Expanded Academic, Global Health, Health Reference Center Academic, OCLC, SCImago, Summon by Serial Solutions".
- Q4914612 abstract "BioDrugs is a peer-reviewed pharmacology journal.It has an impact factor of 2.989.It is published by Adis International (Springer Science + Business Media)BioDrugs aims to advance discussion and evaluation of the latest developments in the clinical application of biotechnology for the treatment of human disease by providing a programme of review articles and original research covering the most important aspects of biotechnology-based pharmaceuticals, diagnostic products and innovations in bio-tech therapy. This includes novel drug delivery systems; protein/peptide therapeutics; monoclonal antibodies, antibody fragments and antibody engineering; biosimilars; cytokines and cytokine receptors; recombinant DNA and gene regulation technology; gene therapy; nucleic acid therapeutics and diagnostics; stem cell therapies; drug target validation; glycolated and pegylated therapeutics; and pioneering technologies in drug design and development. BioDrugs publishes articles on all areas of medicine. Abstracted/Indexed in:- PubMed/Medline, SCOPUS, EMBASE, Google Scholar, EBSCO, CSA, CAB International, Academic OneFile, Academic Search, ASFA, CAB Abstracts, Current Abstracts, Expanded Academic, Global Health, Health Reference Center Academic, OCLC, SCImago, Summon by Serial Solutions".